Skip to main content

pJV62 Citations (3)

Originally described in: Efficient point mutagenesis in mycobacteria using single-stranded DNA recombineering: characterization of antimycobacterial drug targets.
van Kessel JC, Hatfull GF Mol Microbiol. 2008 Mar . 67(5):1094-107.
PubMed Journal

Articles Citing pJV62

Articles
A novel class of antimicrobial drugs selectively targets a Mycobacterium tuberculosis PE-PGRS protein. Seo H, Kim S, Mahmud HA, Islam MI, Yoon Y, Cho HD, Nam KW, Choi J, Gil YS, Lee BE, Song HY. PLoS Biol. 2022 May 31;20(5):e3001648. doi: 10.1371/journal.pbio.3001648. eCollection 2022 May. PubMed
Genome editing outcomes reveal mycobacterial NucS participates in a short-patch repair of DNA mismatches. Islam T, Josephs EA. Nucleic Acids Res. 2024 Nov 11;52(20):12295-12307. doi: 10.1093/nar/gkae402. PubMed
Genome editing of phylogenetically distinct bacteria using portable retron-mediated recombineering. Gonzalez-Delgado A, Bonillo-Lopez L, Johnson MS, Knodlseder N, Ko CC, Lekbach Y, Oh JH, Selvakumar H, Wold MC, Yu Z, Aragon V, Gralnick JA, Guell M, Hatfull GF, Keitz BK, Koskella B, Mutalik VK, van Pijkeren JP, Shipman SL. bioRxiv [Preprint]. 2025 Jul 9:2025.06.16.660010. doi: 10.1101/2025.06.16.660010. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.